Pretreatment of 4T1 breast cancer cells with TGFβ increased their susceptibility to neutrophil-mediated cytotoxicity [68], which might be explained by the more apoptosis-prone mesenchymal phenotype of TGFβ-treated tumor cells [276]. The gene discussed is TGFB1; the disease is breast carcinoma.